scholarly article | Q13442814 |
P356 | DOI | 10.1097/TP.0B013E318222C9C6 |
P698 | PubMed publication ID | 21637139 |
P50 | author | Anthony Dorling | Q37837734 |
Candice Roufosse | Q61114342 | ||
P2093 | author name string | David Taube | |
Adam G McLean | |||
Jack W Galliford | |||
Michelle Willicombe | |||
Anthony N Warrens | |||
Paul Brookes | |||
Tom D Cairns | |||
Terry H Cook | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibody | Q79460 |
P304 | page(s) | 176-182 | |
P577 | publication date | 2011-07-01 | |
P1433 | published in | Transplantation | Q15730500 |
P1476 | title | Antibody-mediated rejection after alemtuzumab induction: incidence, risk factors, and predictors of poor outcome | |
P478 | volume | 92 |
Q52939658 | A refractory case of subclinical antibody-mediated rejection due to anti-HLA-DQ antibody in a kidney transplant patient. |
Q44075598 | Acute cellular and antibody-mediated rejection of the pancreas allograft: incidence, risk factors and outcomes |
Q38544529 | Advances in pharmacotherapy to treat kidney transplant rejection |
Q86254890 | Alemtuzumab induction and antibody-mediated rejection in kidney transplantation |
Q43681319 | Algorithms for the determination of unacceptable HLA antigen mismatches in kidney transplant recipients |
Q37698860 | Antibody-Mediated Rejection: A Review |
Q38206175 | Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options |
Q90696052 | Automated detection algorithm for C4d immunostaining showed comparable diagnostic performance to pathologists in renal allograft biopsy |
Q47313617 | Clinical Significance of Pretransplant Donor-Specific Antibodies in the Setting of Negative Cell-Based Flow Cytometry Crossmatching in Kidney Transplant Recipients |
Q38079301 | Clinical relevance of antibody development in renal transplantation |
Q39025865 | Crosstalk Between T and B Cells in the Germinal Center After Transplantation. |
Q26998713 | Detection and clinical relevance of donor specific HLA antibodies: a matter of debate |
Q34841849 | Diagnosis and management of antibody-mediated rejection: current status and novel approaches |
Q47286616 | Dynamic Prognostic Score to Predict Kidney Allograft Survival in Patients with Antibody-Mediated Rejection. |
Q38022711 | Identification and therapeutic management of highly sensitized patients undergoing renal transplantation. |
Q41782407 | Patterns of de novo allo B cells and antibody formation in chronic cardiac allograft rejection after alemtuzumab treatment. |
Q38212985 | Plasma cell-rich rejection accompanied by acute antibody-mediated rejection in a patient with ABO-incompatible kidney transplantation |
Q52793674 | Proteasome Inhibitor Carfilzomib-Based Therapy for Antibody-Mediated Rejection of the Pulmonary Allograft: Use and Short-Term Findings. |
Q27015093 | Regulatory B cells: an exciting target for future therapeutics in transplantation |
Q38746225 | Review of the Clinical and Economic Burden of Antibody-Mediated Rejection in Renal Transplant Recipients |
Q92381767 | Role of de novo DQ donor-specific antibody in antibody-mediated rejection in renal transplant recipient: A case study |
Q33891696 | The role of B cells in solid organ transplantation. |
Search more.